NEW ORLEANS, May 18, 2018 /PRNewswire/ -- ClaimsFiler, a FREE
shareholder information service, reminds investors that they have
until June 19, 2018 to file
lead plaintiff applications in a securities class action lawsuit
against Myriad Genetics, Inc. (NasdaqGS: MYGN), if they purchased
the Company's securities between August 13,
2014 through March 12, 2018,
inclusive (the "Class Period"). This action is pending in
the United States District Court
for the District of Utah.
Get Help
Myriad investors should visit us at
https://www.claimsfiler.com/cases/view-myriad-genetics-securities-litigation
or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Myriad Genetics and certain of its executives are charged with
failing to disclose material information during the Class Period,
violating federal securities laws.
On March 12, 2018, the Company
revealed that it received a subpoena from the Department of Health
and Human Services, regarding "an investigation into possible false
or otherwise improper claims submitted for payment under Medicare
and Medicaid," specifically relating to the Company's hereditary
cancer testing dating back to January 1,
2014 (less than four months after the Company launched its
myRisk test in September 2013) to the
date of the subpoena's issuance.
On this news, the price of Myriad's shares plummeted over
12.14%
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information
source to help retail investors recover their share of billions of
dollars from securities class action settlements. ClaimsFiler's
team of experts monitor the securities class action landscape and
cull information from a variety of sources to ensure comprehensive
coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
View original
content:http://www.prnewswire.com/news-releases/myriad-genetics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-myriad-genetics-inc---mygn-300651020.html
SOURCE ClaimsFiler